https://www.fool.com/investing/2024/03/09/consumer-sales-in-china-are-still-a-trouble-spot-f/?source=iedfolrf0000001
Mar 09, 2024 - Hormel's business turned for the better in the fiscal first quarter of 2024, but China is still not performing as well as hoped.
0
fool:-181914616266735118
0
https://www.entrepreneur.com/growing-a-business/are-you-underpricing-your-products-heres-how-to-find-out/468841
Mar 09, 2024 - Studies show most incorrectly priced products are priced too low. Learn to bridge the gap between actual and perceived value, identify maximum customer willingness-to-pay and adopt metric-based pricing for increased profitability.
0
ent:-6898689338155158149
0
https://www.ocregister.com/2024/03/08/anthony-joshua-takes-out-francis-ngannou-with-crushing-2nd-round-ko/
Mar 08, 2024 - The former heavyweight champ dominates his matchup with the ex-UFC heavyweight champ in Saudi Arabia, flooring him in the first round and again early in the second, then apparently knocking Ngannou out cold with an unblocked right hand.
0
ocr:-6202741000240396566
0
https://www.ocregister.com/2024/03/08/lakers-lebron-james-to-sit-out-vs-bucks-because-of-ankle/
Mar 08, 2024 - It is the ninth missed game this season for the 39-year-old future Hall of Famer, who was downgraded to out before tip-off and has been dealing with a left ankle injury for months.
0
ocr:-8412973701629731021
0
https://seekingalpha.com/article/4677111-wave-life-sciences-weighty-ambition-carving-out-obesity-niche?source=feed_all_articles
Mar 08, 2024 - Wave enters the obesity market with INHBE clinical candidate, but faces fierce competition, financial concerns, and mixed market sentiment. Read my analysis of WVE.
0
sa:-6609445621869631648
0
https://seekingalpha.com/article/4677101-medical-properties-trust-down-but-not-out-rating-upgrade?source=feed_all_articles
Mar 08, 2024 - Medical Properties Trust is undervalued but has a high dividend yield, making it an attractive investment. Find out why MPW stock is upgraded from Hold to Buy.
0
sa:-1990176009308844925
0
https://www.zacks.com/stock/news/2237986/zuora-zuo-recently-broke-out-above-the-50-day-moving-average?cid=CS-ZC-FT-tale_of_the_tape|50_day_moving_average_(yseop)-2237986
Mar 08, 2024 - Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
zc:2528472518920454694
0
https://www.zacks.com/stock/news/2237877/how-acm-research-acmr-stock-stands-out-in-a-strong-industry?cid=CS-ZC-FT-tale_of_the_tape|industry_rank_and_rising_estimates-2237877
Mar 08, 2024 - ACM Research (ACMR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
zc:2337449105899453369
0
https://www.zacks.com/stock/news/2237883/how-assetmark-amk-stock-stands-out-in-a-strong-industry?cid=CS-ZC-FT-tale_of_the_tape|industry_rank_and_rising_estimates-2237883
Mar 08, 2024 - AssetMark (AMK) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
zc:6063752675931225074
0
https://seekingalpha.com/news/4077324-cigna-eyes-0-out-of-pocket-humira-biosimilar?source=feed_sector_healthcare
Mar 07, 2024 - Health insurer Cigna (CI) plans to launch a biosimilar for AbbVie's (ABBV) arthritis therapy Humira with $0 out-of-pocket expenses for eligible patients. Read more here.
0
sa:2858382721667433806
0